Shares of Oncocyte were soaring higher this week as Wall Street learned that the company has signed a licensing deal with China’s Burning Rock Biotech. The cancer detection company said it has licensed a lung cancer test to Burning Rock Biotech BNR for use in that country. The test, dubbed DetermaRx, is meant to identify … Continue reading “Oncocyte Shares Explode on Licensing Deal with China’s Burning Rock Biotech”
